(Q71519298)
English
Intensive chemotherapy for poor prognosis myelodysplasia (MDS) and secondary acute myeloid leukemia (sAML) following MDS of more than 6 months duration. A pilot study by the Leukemia Cooperative Group of the European Organisation for Research and Tr
scientific article published on 01 November 1995
Statements
Intensive chemotherapy for poor prognosis myelodysplasia (MDS) and secondary acute myeloid leukemia (sAML) following MDS of more than 6 months duration. A pilot study by the Leukemia Cooperative Group of the European Organisation for Research and Treatment in Cancer (EORTC-LCG) (English)
de Witte T
Suciu S
Peetermans M
Strijckmans P
Hayat M
Jaksic B
Selleslag D
Zittoun R
1 November 1995